Paragon Biosciences is a company that has made a tremendous impact in recent times. Paragon is an investor that has made its name by building and expanding biotechnology companies. They have a passion for helping people to live healthier lives (http://reporterexpert.com/jeff-aronin-paragonbiosci/). Their incredible success is centered around their philosophy: begin with what the patient needs, understand the science and work to build companies that can help.
Paragon Biosciences is determined to solve those problems which have not been solved. They have a set of four companies that complete their work: Castle Creek, Decade, Harmony Biosciences and Precision BP. All four of these companies are disciplined and use specific strategies to complete their work. Perhaps the biggest member of this group is Castle Creek. Castle Creek is a privately held company that is creating and developing therapies for rare and serious conditions. In a short time, they have created a number of diverse products that have the ability to change the health of many people.
With more than two decades of experience, Jeff Aronin has been a huge part of Paragon’s success. Currently, Aronin serves as the chairman and chief executive officer of Paragon Biosciences. Aronin has years of experience developing global healthcare innovation companies. His expertise is in both complex science and rare diseases. These talents have allowed him to assemble a top-notch team and lead his current company. As of today, Aronin and his team have succeeded in getting 13 major drug approvals through the FDA. This rate is much higher than nearly all of his competitors.
Jeff Aronin spent nearly a decade as the president and chief executive officer of Ovation Pharmaceuticals Inc. He continued serving as president and chief executive officer when the company was acquired by Lundbeck. Aronin has built quite an impressive resume during his career. With such an incredible track record, he is sure to have continued success for many more years to come.